title: Surgical resection of metastasis to the pancreas.
abstract: OBJECTIVE
  Metastasis to the pancreas is rare, and the benefit of resection for pancreatic metastasis is poorly defined. The aim of this study was to review our experiences of the operative management of metastasis to the pancreas.
  
  
  METHODS
  Between 1995 and 2009, 11 patients (8 men and 3 women; median age, 54 years) were admitted to our institution with a metachronously metastatic lesion to the pancreas and later underwent pancreatic resection. The clinical features and outcomes of treatments were examined.
  
  
  RESULTS
  The primary cancers were renal cell carcinoma (RCC, n = 7), carcinoid tumor (n = 2), rectal cancer and leiomyosarcoma. Six patients underwent distal pancreatectosplenectomy, 3 pancreaticoduodenectomy and 2 patients underwent enucleation for small RCC. One patient died of metastatic RCC at 53 months after surgery and ten patients remain alive; four patients without disease at 7 to 69 months postoperatively, and the other six with disease at 11 to 68 months. Median postoperative survival of all patients was 34 months.
  
  
  CONCLUSIONS
  Patients with a low surgical risk should be considered for pancreatic metastasectomy if curative resection is possible. Primary cancer type, which is associated with survival benefit, would be the best candidate for surgical resection of metastases to the pancreas.
authors: Department of Surgery, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
authors: Dong Do
authors: DD
authors: You
authors: Dong Wook
authors: DW
authors: Choi
authors: Seong Ho
authors: SH
authors: Choi
authors: Jin Seok
authors: JS
authors: Heo
authors: Woo Suk
authors: WS
authors: Kim
authors: Cheon Yu
authors: CY
authors: Ho
authors: Hyung Geun
authors: HG
authors: Lee